T-cell cytokine-inducing surface molecules and methods of use

Details for Australian Patent Application No. 2008261030 (hide)

Owner The Regents of the University of Colorado

Inventors Li, Li; Edwards III, Carl Keith; Jonscher, Karen R.

Agent Spruson & Ferguson

Pub. Number AU-A-2008261030

PCT Pub. Number WO2008/151307

Priority 60/942,041 05.06.07 US

Filing date 5 June 2008

Wipo publication date 11 December 2008

International Classifications

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

28 January 2010 PCT application entered the National Phase

  PCT publication WO2008/151307 Priority application(s): WO2008/151307

13 January 2011 Assignment before Grant

  The Regents of the University of Colorado The application has been assigned to Western States Biopharmaceuticals, Inc.

14 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008261042-Expression of soluble antibody fragment by truncation of CH1 domain

2008261027-Selective inhibitors for cyclin-dependent kinases